Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 4
1993 1
1998 2
2000 2
2001 1
2002 1
2004 1
2006 4
2007 1
2008 2
2010 3
2013 2
2014 4
2015 3
2016 1
2018 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.
Motzer RJ, Escudier B, McDermott DF, Arén Frontera O, Melichar B, Powles T, Donskov F, Plimack ER, Barthélémy P, Hammers HJ, George S, Grünwald V, Porta C, Neiman V, Ravaud A, Choueiri TK, Rini BI, Salman P, Kollmannsberger CK, Tykodi SS, Grimm MO, Gurney H, Leibowitz-Amit R, Geertsen PF, Amin A, Tomita Y, McHenry MB, Saggi SS, Tannir NM. Motzer RJ, et al. Among authors: geertsen pf. J Immunother Cancer. 2020 Jul;8(2):e000891. doi: 10.1136/jitc-2020-000891. J Immunother Cancer. 2020. PMID: 32661118 Free PMC article. Clinical Trial.
Patterns of care in oligometastatic disease: the clinicians' perspective.
Felter MVO, Josipovic M, Serup-Hansen E, Geertsen PF, Behrens CF, Khalil AA, Persson GF. Felter MVO, et al. Among authors: geertsen pf. Acta Oncol. 2022 Sep;61(9):1148-1151. doi: 10.1080/0284186X.2022.2114380. Epub 2022 Aug 25. Acta Oncol. 2022. PMID: 36017569 No abstract available.
The value of gynecologic cancer follow-up: evidence-based ignorance?
Lajer H, Jensen MB, Kilsmark J, Albæk J, Svane D, Mirza MR, Geertsen PF, Reerman D, Hansen K, Milter MC, Mogensen O. Lajer H, et al. Among authors: geertsen pf. Int J Gynecol Cancer. 2010 Nov;20(8):1307-20. doi: 10.1111/IGC.0b013e3181f3bee0. Int J Gynecol Cancer. 2010. PMID: 21051970 Review.
[Interleukin-2 based immunotherapy of cancer].
Geertsen PF, Hermann GG, Claësson MH, Steven K, Zeuthen J, von der Maase H. Geertsen PF, et al. Ugeskr Laeger. 1990 Nov 19;152(47):3513-7. Ugeskr Laeger. 1990. PMID: 2256204 Review. Danish.
KRAS and BRAF mutations in anal carcinoma.
Serup-Hansen E, Linnemann D, Høgdall E, Geertsen PF, Havsteen H. Serup-Hansen E, et al. Among authors: geertsen pf. APMIS. 2015 Jan;123(1):53-9. doi: 10.1111/apm.12306. Epub 2014 Sep 22. APMIS. 2015. PMID: 25244542
Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma.
McDermott DF, Lee JL, Bjarnason GA, Larkin JMG, Gafanov RA, Kochenderfer MD, Jensen NV, Donskov F, Malik J, Poprach A, Tykodi SS, Alonso-Gordoa T, Cho DC, Geertsen PF, Climent Duran MA, DiSimone C, Silverman RK, Perini RF, Schloss C, Atkins MB. McDermott DF, et al. Among authors: geertsen pf. J Clin Oncol. 2021 Mar 20;39(9):1020-1028. doi: 10.1200/JCO.20.02363. Epub 2021 Feb 2. J Clin Oncol. 2021. PMID: 33529051 Free PMC article. Clinical Trial.
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma.
Powles T, Motzer RJ, Escudier B, Pal S, Kollmannsberger C, Pikiel J, Gurney H, Rha SY, Park SH, Geertsen PF, Gross-Goupil M, Grande E, Suarez C, Markby DW, Arroyo A, Dean M, Choueiri TK, George D. Powles T, et al. Among authors: geertsen pf. Br J Cancer. 2018 Sep;119(6):663-669. doi: 10.1038/s41416-018-0164-0. Epub 2018 Sep 10. Br J Cancer. 2018. PMID: 30197417 Free PMC article. Clinical Trial.
35 results